215 related articles for article (PubMed ID: 26894488)
41. Gonadotropin-releasing hormone agonists and laparoscopy in the treatment of adenomyosis with infertility.
Lin J; Sun C; Zheng H
Chin Med J (Engl); 2000 May; 113(5):442-5. PubMed ID: 11776101
[TBL] [Abstract][Full Text] [Related]
42. Risk Factors for Symptomatic Recurrence after Laparoscopic Adenomyomectomy: A 3-Year Follow-up.
Sun F; Yu J; Pan Y; Huo X; Yang Y; Xu H
J Minim Invasive Gynecol; 2023 Jul; 30(7):555-561. PubMed ID: 36889669
[TBL] [Abstract][Full Text] [Related]
43. Laparoscopically assisted Adenomyomectomy Using the Double/Multiple-Flap Method with Temporary Occlusion of the Bilateral Uterine Artery and Utero-Ovarian Vessels in Comparison with the Double/Multiple-Flap Only Method.
Ji L; Jin L; Zheng S; Shao M; Cui D; Hu M
Geburtshilfe Frauenheilkd; 2021 Mar; 81(3):321-330. PubMed ID: 33692593
[No Abstract] [Full Text] [Related]
44. Conservative surgical management for diffuse uterine adenomyosis.
Nishida M; Takano K; Arai Y; Ozone H; Ichikawa R
Fertil Steril; 2010 Jul; 94(2):715-9. PubMed ID: 19406396
[TBL] [Abstract][Full Text] [Related]
45. Fertility-sparing surgery for diffuse adenomyosis: a narrated, stepwise approach to the Osada procedure.
Lu C; Corbett C; Elliott JE; Evans D
Fertil Steril; 2022 Sep; 118(3):588-590. PubMed ID: 35961921
[TBL] [Abstract][Full Text] [Related]
46. Long-term results of uterine artery embolization for symptomatic adenomyosis.
Kim MD; Kim S; Kim NK; Lee MH; Ahn EH; Kim HJ; Cho JH; Cha SH
AJR Am J Roentgenol; 2007 Jan; 188(1):176-81. PubMed ID: 17179361
[TBL] [Abstract][Full Text] [Related]
47. Outcome of uterine functional structures protection by fertility preservative PUSH surgery in diffuse adenomyosis.
Wu R; Zeng L; Hu Q; Qu X; He F; Bao J; Wei W; Zhang W; Dai W; Li H; Du H; Li C
Hum Fertil (Camb); 2023 Oct; 26(4):720-732. PubMed ID: 37913797
[TBL] [Abstract][Full Text] [Related]
48. Long-term follow-up of severely symptomatic women with adenomyoma treated with combination therapy.
Liu WM; Chen CH; Chiu LH; Tzeng CR
Taiwan J Obstet Gynecol; 2013 Mar; 52(1):85-9. PubMed ID: 23548225
[TBL] [Abstract][Full Text] [Related]
49. Outcomes in Adenomyosis Treated with Uterine Artery Embolization Are Associated with Lesion Vascularity: A Long-Term Follow-Up Study of 252 Cases.
Zhou J; He L; Liu P; Duan H; Zhang H; Li W; Gong S; Su G; Chen C
PLoS One; 2016; 11(11):e0165610. PubMed ID: 27806072
[TBL] [Abstract][Full Text] [Related]
50. Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest.
Matsushima T; Akira S; Yoneyama K; Takeshita T
Gynecol Endocrinol; 2020 Jun; 36(6):521-524. PubMed ID: 31661345
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of percutaneous microwave ablation for adenomyosis in the posterior uterine wall.
Zhang HL; Yu SY; Li XL; Zhu JE; Li JX; Sun LP; Xu HX
Br J Radiol; 2023 Nov; 96(1151):20211301. PubMed ID: 37017557
[TBL] [Abstract][Full Text] [Related]
52. Current and Future Surgical and Interventional Management Options for Adenomyosis.
Chen J; Porter AE; Kho KA
Semin Reprod Med; 2020 May; 38(2-03):157-167. PubMed ID: 33152768
[TBL] [Abstract][Full Text] [Related]
53. [How I do… to perform uterine adenomyomectomy].
Arfi A; Chevalier AS; Sroussi J; Mezzadri M; Benifla JL
Gynecol Obstet Fertil Senol; 2017 May; 45(5):320-322. PubMed ID: 28499673
[No Abstract] [Full Text] [Related]
54. A clinical audit on the efficacy and safety of uterine artery embolisation for symptomatic adenomyosis: Results in 117 women.
Liang E; Brown B; Rachinsky M
Aust N Z J Obstet Gynaecol; 2018 Aug; 58(4):454-459. PubMed ID: 29344938
[TBL] [Abstract][Full Text] [Related]
55. Operation, hormone therapy and recovery of the patients with severe forms of adenomyosis.
Tskhay V; Schindler AE; Мikailly G
Gynecol Endocrinol; 2018 Aug; 34(8):647-650. PubMed ID: 29447009
[TBL] [Abstract][Full Text] [Related]
56. Characteristics and efficacy of modified adenomyomectomy in the treatment of uterine adenomyoma.
Sun AJ; Luo M; Wang W; Chen R; Lang JH
Chin Med J (Engl); 2011 May; 124(9):1322-6. PubMed ID: 21740741
[TBL] [Abstract][Full Text] [Related]
57. Maintenance dienogest therapy following adjuvant gonadotropin-releasing hormone agonist treatment after uterus-sparing surgery in adenomyosis: A retrospective cohort study.
Chan IS; Hsu TF; Shih YC; Chang YH; Wang PH; Chen YJ
Int J Gynaecol Obstet; 2023 Jun; 161(3):751-759. PubMed ID: 36527263
[TBL] [Abstract][Full Text] [Related]
58. A cohort study of the efficacy of the dienogest and the gonadotropin-releasing hormone agonist in women with adenomyosis and dysmenorrhea.
Ji M; Yuan M; Jiao X; Li Q; Huang Y; Li J; Wang G
Gynecol Endocrinol; 2022 Feb; 38(2):164-169. PubMed ID: 34749585
[TBL] [Abstract][Full Text] [Related]
59. Implementation of a robotic surgical program in gynaecological oncology and comparison with prior laparoscopic series.
Povolotskaya N; Woolas R; Brinkmann D
Int J Surg Oncol; 2015; 2015():814315. PubMed ID: 25785195
[TBL] [Abstract][Full Text] [Related]
60. Distinct types of uterine adenomyosis based on laparoscopic and histopathologic criteria.
Pistofidis G; Makrakis E; Koukoura O; Bardis N; Balinakos P; Anaf V
Clin Exp Obstet Gynecol; 2014; 41(2):113-8. PubMed ID: 24779231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
